Cancer drug price cuts leave costly brands untouchedPrices of several anti-cancer drugs are set to fall significantly starting November 9, offering some financial relief. However, the prices ...
29 Oct, 2026, 11.46 AM IST
Cipla sets sights on first-wave gains from rollout of Keytruda BiosimilarCipla has partnered with Qilu Pharmaceutical to commercialize a biosimilar of Keytruda, which is a major cancer treatment. The patent for t...
28 Oct, 2026, 01.31 AM IST
Rs 1 lakh to Rs 30,000: Cancer immunotherapy gets cheaper, but will patients get the price benefit?Cheaper nivolumab biosimilars are expanding access to cancer immunotherapy in India, with one Mumbai oncologist reporting a more than 50% r...
27 Oct, 2026, 05.01 PM IST
Pope Leo cancer diagnosis: What is lung adenocarcinoma, symptoms, treatments & who are at riskPope Leo has been found to have lung adenocarcinoma, which is among the most common types of lung cancer. He recently had surgery to excise...
14 Oct, 2026, 01.55 PM IST
Zydus moves closer to US market for Keytruda biosimilar as FDA accepts applicationZydus Lifesciences has received acceptance for its application regarding the biosimilar of Keytruda, which is a major cancer drug. The USFD...
14 Oct, 2026, 12.32 AM IST
Why is Summit Therapeutics share price up today by 22%?Summit Therapeutics share price is up today by 22% after biopharma firm announced AstraZeneca would invest $2 billion in it. British drugma...
29 Sep, 2026, 08.18 PM IST
Benjamin Satterley death: From Bray Wyatt to Andre the Giant to Chyna, WWE stars who died before the age of 50Benjamin Satterley, a talented professional wrestler from England, passed away at the age of 40. All Elite Wrestling confirmed the sad news...
28 Sep, 2026, 05.10 PM IST
India needs five-year policy to make precision cancer care afforable, says expertIndia needs a five-year roadmap to expand access to genomic testing and targeted cancer therapies for lower-income patients, oncologist Dr ...
26 Sep, 2026, 02.18 PM IST
Dr. Reddy's launches nivolumab biosimilar in IndiaDr Reddy's Laboratories has taken a significant step in cancer care with the introduction of NIVORZ, a biosimilar of nivolumab. Designed to...
15 Sep, 2026, 07.35 PM IST
Glenmark initiates multi-nation Phase 3 clinical trial for lung cancer drugGlenmark Pharmaceuticals has commenced a Phase 3 clinical trial across multiple countries, including India, Russia, Brazil, and Mexico, for...
05 Sep, 2025, 04.46 PM IST
You thought only DeepSeek routed American titans? Wait, here's a little-known Chinese biotech company whose lung cancer drug could rattle big pharma; here's all about itChinese biotech company Akeso developed a lung cancer drug Ivonescimab, which outperformed Merck's Keytruda in trials. This breakthrough si...
26 Feb, 2025, 10.45 PM IST
Bristol Myers to buy Mirati for $4.8 billionThe purchase will give a boost to Bristol as patent expirations weigh on sales of its oncology medicines. The company had to slash its reve...
09 Oct, 2023, 11.43 PM IST
- New method to make lung cancer drug trials more successful
Melbourne, June 14 (IANS) Australian researchers have developed a new method for finding participants in clinical trials of lung cancer dru...
14 Jun, 2017, 02.53 PM IST
Good cancer drug data helps AstraZeneca in Pfizer fightBritain's second-biggest drugmaker has rejected a $106 billion approach from its US rival Pfizer, arguing that it has a bright future.
15 May, 2014, 02.20 PM IST
Cadila Pharmaceuticals launches lung cancer drugThe company claims that the drug Mycidac-C is for the first time in the world an affordable, unique and innovative drug for the treatment o...
21 Nov, 2013, 05.09 PM IST
New drug could potentially treat lung cancerThe drug has shown early potential as an effective treatment for non-small cell lung cancer, the leading cause of cancer death worldwide.
04 Nov, 2013, 03.20 PM IST
- Pfizer warns of lung cancer link with inhaled insulin
US drugmakers Pfizer Inc and Nektar Therapeutics warned of cases of lung cancer in clinical trials of their inhaled insulin Exubera.
10 Apr, 2008, 09.14 AM IST